75907-0405 Bosutinib - CanMED: NDC

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

75907-0405

Brand Name:

Bosutinib

Generic Name:

Bosutinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: BOSUTINIB

Strength: 400.0

Unit: mg/1

Packages:

Code: 75907-0405-30

Description: 30 TABLET, FILM COATED in 1 BOTTLE (75907-405-30)

Effective Date: June 12, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use